JP2020502225A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020502225A5 JP2020502225A5 JP2019534090A JP2019534090A JP2020502225A5 JP 2020502225 A5 JP2020502225 A5 JP 2020502225A5 JP 2019534090 A JP2019534090 A JP 2019534090A JP 2019534090 A JP2019534090 A JP 2019534090A JP 2020502225 A5 JP2020502225 A5 JP 2020502225A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- composition according
- alkyl
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE1651706-2 | 2016-12-21 | ||
| SE1651706 | 2016-12-21 | ||
| PCT/GB2017/053868 WO2018115891A1 (en) | 2016-12-21 | 2017-12-21 | Triazinetrione derivatives and their use as modulators of neurotrophin receptor and receptor tyrosine kinases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020502225A JP2020502225A (ja) | 2020-01-23 |
| JP2020502225A5 true JP2020502225A5 (https=) | 2021-02-04 |
Family
ID=60923799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019534090A Pending JP2020502225A (ja) | 2016-12-21 | 2017-12-21 | トリアジントリオン誘導体、ならびにニューロトロフィン受容体および受容体型チロシンキナーゼのモジュレーターとしてのその使用。 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20200113910A1 (https=) |
| EP (1) | EP3558320A1 (https=) |
| JP (1) | JP2020502225A (https=) |
| KR (1) | KR20190098982A (https=) |
| CN (1) | CN110167558A (https=) |
| AU (1) | AU2017380583A1 (https=) |
| BR (1) | BR112019012709A2 (https=) |
| CA (1) | CA3046289A1 (https=) |
| IL (1) | IL267086A (https=) |
| MX (1) | MX2019007606A (https=) |
| RU (1) | RU2019120431A (https=) |
| WO (1) | WO2018115891A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA52415A (fr) | 2018-02-26 | 2021-01-06 | AlzeCure Pharma AB | Dérivés de triazine pour le traitement de maladies associées à des neurotrophines |
| GB201810668D0 (en) | 2018-06-28 | 2018-08-15 | Stiftelsen Alzecure | New compounds |
| GB201912404D0 (en) * | 2019-08-29 | 2019-10-16 | AlzeCure Pharma AB | New compounds |
| CN113057957A (zh) * | 2021-03-30 | 2021-07-02 | 福建中医药大学 | 葛杜宁及其衍生物在制备抗氧化药物和/或化妆品及治疗类风湿性关节炎药物中的用途 |
| CN113893334A (zh) * | 2021-10-19 | 2022-01-07 | 内蒙古医科大学第二附属医院 | 基于cAMP/PKA-CREB-BDNF信号通路的七氟烷影响抑制剂及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2718799A1 (de) | 1977-04-27 | 1978-11-09 | Bayer Ag | 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer |
| KR101457027B1 (ko) * | 2009-06-09 | 2014-10-31 | 캘리포니아 캐피탈 에쿼티, 엘엘씨 | 트리아진 유도체와 이들의 치료적 용도 |
| CN103180297A (zh) * | 2009-12-11 | 2013-06-26 | 基因密码公司 | 使用gdnf家族配体(gfl)模拟剂或ret信号传导通路活化剂促进神经细胞存活的方法 |
-
2017
- 2017-12-21 JP JP2019534090A patent/JP2020502225A/ja active Pending
- 2017-12-21 CA CA3046289A patent/CA3046289A1/en not_active Abandoned
- 2017-12-21 AU AU2017380583A patent/AU2017380583A1/en not_active Abandoned
- 2017-12-21 US US16/471,923 patent/US20200113910A1/en not_active Abandoned
- 2017-12-21 EP EP17825283.9A patent/EP3558320A1/en not_active Withdrawn
- 2017-12-21 BR BR112019012709A patent/BR112019012709A2/pt not_active Application Discontinuation
- 2017-12-21 WO PCT/GB2017/053868 patent/WO2018115891A1/en not_active Ceased
- 2017-12-21 MX MX2019007606A patent/MX2019007606A/es unknown
- 2017-12-21 KR KR1020197018642A patent/KR20190098982A/ko not_active Ceased
- 2017-12-21 CN CN201780078675.XA patent/CN110167558A/zh active Pending
- 2017-12-21 RU RU2019120431A patent/RU2019120431A/ru not_active Application Discontinuation
-
2019
- 2019-06-04 IL IL267086A patent/IL267086A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020502225A5 (https=) | ||
| JP6134046B1 (ja) | 医療で使用されるインドール誘導体 | |
| RU2468025C2 (ru) | Терапевтические агенты | |
| JP2017524005A5 (https=) | ||
| RU2019120431A (ru) | Производные триазинтриона и их использование в качестве модуляторов нейротрофиновых рецепторов и рецепторов тирозинкиназ | |
| IL276624B1 (en) | Triazine derivatives for the treatment of neurotrophin-related diseases | |
| JP2004534816A5 (https=) | ||
| JP2005194283A5 (https=) | ||
| JP6837479B2 (ja) | 医薬化合物 | |
| JP2020532547A5 (https=) | ||
| JP2010540562A5 (https=) | ||
| JP2009523822A5 (https=) | ||
| JP2015531764A5 (https=) | ||
| JP2013536833A5 (https=) | ||
| JP2009538910A5 (https=) | ||
| JP2019535825A5 (https=) | ||
| JP2021514963A5 (https=) | ||
| RU2006114749A (ru) | Производные пиразоло- и имидазопиримидина | |
| KR20200089292A (ko) | 눈 질환의 치료를 위한 조성물 및 방법 | |
| FI120403B (fi) | 4-(2-amino-6-(syklopropyyliamino)-9H-purin-9-yyli)-2-syklopenteeni-1-metanoli-sukkinaatti viruksia torjuvana aineena | |
| JP2016525104A5 (https=) | ||
| JPS6042374A (ja) | 新規な１，５−ベンゾチアゼピン類、それらの製造方法およびそれらを含有している製薬学的組成物 | |
| CN106488907A (zh) | O‑烷基‑苯亚甲基胍衍生物及其治疗与错误折叠蛋白质累积有关疾病的治疗用途 | |
| JP2006516643A5 (https=) | ||
| CN110891942A (zh) | 噁二唑类衍生物、其制备方法及其在医药上的应用 |